vs

Side-by-side financial comparison of Cambium Networks Corp (CMBM) and Medirom Healthcare Technologies Inc. (MRM). Click either name above to swap in a different company.

Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $21.1M, roughly 1.9× Medirom Healthcare Technologies Inc.). Cambium Networks Corp runs the higher net margin — -17.9% vs -21.3%, a 3.4% gap on every dollar of revenue. Medirom Healthcare Technologies Inc. produced more free cash flow last quarter ($-2.4K vs $-10.8M).

Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.

Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.

CMBM vs MRM — Head-to-Head

Bigger by revenue
CMBM
CMBM
1.9× larger
CMBM
$40.3M
$21.1M
MRM
Higher net margin
CMBM
CMBM
3.4% more per $
CMBM
-17.9%
-21.3%
MRM
More free cash flow
MRM
MRM
$10.8M more FCF
MRM
$-2.4K
$-10.8M
CMBM

Income Statement — Q4 FY2024 vs Q2 FY2025

Metric
CMBM
CMBM
MRM
MRM
Revenue
$40.3M
$21.1M
Net Profit
$-7.2M
$-4.5M
Gross Margin
36.6%
10.8%
Operating Margin
-28.4%
-28.5%
Net Margin
-17.9%
-21.3%
Revenue YoY
-23.2%
Net Profit YoY
71.0%
EPS (diluted)
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBM
CMBM
MRM
MRM
Q2 25
$21.1M
Q4 24
$40.3M
Q3 24
$44.7M
Q2 24
$45.2M
Q1 24
$47.1M
Q4 23
$52.5M
Q3 23
$44.6M
Q2 23
$53.7M
Net Profit
CMBM
CMBM
MRM
MRM
Q2 25
$-4.5M
Q4 24
$-7.2M
Q3 24
$-34.5M
Q2 24
$-14.2M
Q1 24
$-18.4M
Q4 23
$-24.9M
Q3 23
$-36.4M
Q2 23
$-13.4M
Gross Margin
CMBM
CMBM
MRM
MRM
Q2 25
10.8%
Q4 24
36.6%
Q3 24
43.6%
Q2 24
32.5%
Q1 24
29.8%
Q4 23
15.2%
Q3 23
26.7%
Q2 23
39.0%
Operating Margin
CMBM
CMBM
MRM
MRM
Q2 25
-28.5%
Q4 24
-28.4%
Q3 24
-69.6%
Q2 24
-27.2%
Q1 24
-33.1%
Q4 23
-44.5%
Q3 23
-46.2%
Q2 23
-20.9%
Net Margin
CMBM
CMBM
MRM
MRM
Q2 25
-21.3%
Q4 24
-17.9%
Q3 24
-77.3%
Q2 24
-31.5%
Q1 24
-39.2%
Q4 23
-47.5%
Q3 23
-81.5%
Q2 23
-25.0%
EPS (diluted)
CMBM
CMBM
MRM
MRM
Q2 25
Q4 24
$-0.26
Q3 24
$-1.22
Q2 24
$-0.51
Q1 24
$-0.66
Q4 23
$-0.90
Q3 23
$-1.32
Q2 23
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBM
CMBM
MRM
MRM
Cash + ST InvestmentsLiquidity on hand
$252.3K
Total DebtLower is stronger
$67.6M
$8.8M
Stockholders' EquityBook value
$-3.2M
$1.6M
Total Assets
$173.7M
$52.0M
Debt / EquityLower = less leverage
5.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBM
CMBM
MRM
MRM
Q2 25
$252.3K
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Q2 23
Total Debt
CMBM
CMBM
MRM
MRM
Q2 25
$8.8M
Q4 24
$67.6M
Q3 24
$67.6M
Q2 24
$68.9M
Q1 24
$63.8M
Q4 23
$25.1M
Q3 23
$25.8M
Q2 23
$26.4M
Stockholders' Equity
CMBM
CMBM
MRM
MRM
Q2 25
$1.6M
Q4 24
$-3.2M
Q3 24
$1.9M
Q2 24
$34.1M
Q1 24
$45.0M
Q4 23
$61.1M
Q3 23
$82.5M
Q2 23
$116.5M
Total Assets
CMBM
CMBM
MRM
MRM
Q2 25
$52.0M
Q4 24
$173.7M
Q3 24
$194.3M
Q2 24
$221.1M
Q1 24
$219.8M
Q4 23
$209.1M
Q3 23
$222.4M
Q2 23
$275.7M
Debt / Equity
CMBM
CMBM
MRM
MRM
Q2 25
5.55×
Q4 24
Q3 24
36.12×
Q2 24
2.02×
Q1 24
1.42×
Q4 23
0.41×
Q3 23
0.31×
Q2 23
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBM
CMBM
MRM
MRM
Operating Cash FlowLast quarter
$-10.4M
$-2.3K
Free Cash FlowOCF − Capex
$-10.8M
$-2.4K
FCF MarginFCF / Revenue
-26.8%
-0.0%
Capex IntensityCapex / Revenue
1.1%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBM
CMBM
MRM
MRM
Q2 25
$-2.3K
Q4 24
$-10.4M
Q3 24
$8.9M
Q2 24
$2.4M
Q1 24
$-15.9M
Q4 23
$-5.8M
Q3 23
$-345.0K
Q2 23
$-4.5M
Free Cash Flow
CMBM
CMBM
MRM
MRM
Q2 25
$-2.4K
Q4 24
$-10.8M
Q3 24
$6.8M
Q2 24
$87.0K
Q1 24
$-17.4M
Q4 23
$-7.4M
Q3 23
$-1.5M
Q2 23
$-5.2M
FCF Margin
CMBM
CMBM
MRM
MRM
Q2 25
-0.0%
Q4 24
-26.8%
Q3 24
15.2%
Q2 24
0.2%
Q1 24
-37.0%
Q4 23
-14.0%
Q3 23
-3.3%
Q2 23
-9.7%
Capex Intensity
CMBM
CMBM
MRM
MRM
Q2 25
0.0%
Q4 24
1.1%
Q3 24
4.8%
Q2 24
5.1%
Q1 24
3.3%
Q4 23
3.1%
Q3 23
2.5%
Q2 23
1.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMBM
CMBM

Enterprise$16.6M41%
Point To Multi Point$16.4M41%
Other$5.8M14%

MRM
MRM

Professional services expense$20.0M95%
Other$1.1M5%

Related Comparisons